Replies to post #30896 on RespireRx Pharmaceuticals Inc (fka RSPI)

[RBlatch45]

My guess David, is that they don't have enough people having completed the actual trial, and thus the change in reviewing the info by the end of September.

I don't think they have any dice to roll.

Cordially,
RBlatch